Medicanna Pharmaceuticals

Medicanna Pharmaceuticals is rated 3 out of 5 in the category medicanna medicinal cannabis pharmaceuticals. Read and write reviews about Medicanna Pharmaceuticals. Medicanna is set to take the lead in the cultivation and production of organic medicinal cannabis whilst executing best organic practice methods. Medicanna will create and advance genetic breeding programs to develop further strains that will benefit a range of medical conditions. Dedicated to working alongside leading researchers and universities for ongoing research and development, evaluation and education, Medicanna will be able to shine the light on medical cannabis and its many medicinal uses. The business model is designed to expand profitability rapidly while maintaining integrity and quality of product. This in turn gives rise to a purer, more organic product to which the patient will reap tremendous medical benefits and allow investor satisfaction. Regulated medical cannabis is susceptible to high risks, growing conditions of the plant, air and water purity, content of fertilizer and light can influence the cannabinoid (CBD) content greatly which emphasizes the importance of Medicanna’s unique methods and strict quality control. Medicanna’s business model is designed to expand profitability rapidly while maintaining integrity of the product. This will give rise to a purer, more organic product from which patients will reap tremendous benefit, which will in turn support the business’s viability. Medicanna Pharmaceutical is backed by a Malaysian financial conglomerate. We have secured initial discussions on multiple sites in South East Asia with a minimum of 200,000sqf greenhouse grow space capable of producing 20,000 - 30,000 kilograms of medicinal cannabis per annum.